Skip to content

Short-Term Health Outcomes of Cooking UFP Exposure

Short-Term Health Outcomes of Cooking UFP Exposure

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07311967
Acronym
UFP
Enrollment
15
Registered
2025-12-31
Start date
2026-01-02
Completion date
2026-06-01
Last updated
2025-12-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Air Pollution Exposure, Cognitive Function Decline, Respiratory Inflammation

Keywords

Cooking emissions, Neurocognitive function, Respiratory symptoms, Ultrafine particles

Brief summary

This study examines the short-term respiratory and cognitive effects of exposure to ultrafine particles (UFPs) generated during typical household cooking. Healthy adults will complete two 6-hour sessions in a controlled exposure chamber at the University of Illinois Chicago: one control day with clean indoor air and one exposure day during which standardized cooking (frying potatoes and grilling beef) is performed by research staff. Participants will not cook or handle food. Lung function will be measured using peak expiratory flow (PEF), and cognitive performance will be assessed using validated tests including the Hopkins Verbal Learning Test-Revised and the Processing Speed Index from the WAIS-IV. Airborne particle and gas concentrations in the chamber will be continuously monitored to ensure that exposures remain within levels typical of everyday home cooking. Findings will help characterize acute physiological responses to indoor cooking emissions and inform future research on indoor air quality and potential mitigation strategies.

Detailed description

This study evaluates the short-term respiratory and cognitive responses to controlled exposure to cooking-generated ultrafine particles (UFPs). Cooking emissions are one of the most common sources of indoor particulate pollution, yet their acute physiological effects remain poorly characterized. To address this gap, the study uses a controlled exposure chamber environment that reproduces typical household cooking conditions while allowing precise measurement of airborne particle and gas concentrations. Healthy adult volunteers will participate in two study sessions conducted on consecutive days. On the exposure day, research staff will prepare a standardized meal (frying potatoes and grilling beef) inside the chamber to generate UFPs and co-emitted gases at levels representative of home cooking. On the control day, participants remain in the same chamber but without any cooking activity. Participants will spend approximately six hours in the chamber each day and will remain at rest except during scheduled assessments. The study employs a randomized two-period crossover design so each participant serves as their own control. Lung function and cognitive performance are assessed multiple times on each day using validated instruments. Air quality is monitored continuously using particle sizing instruments, particle mass monitors, and a gas analyzer to characterize exposure conditions. Pre-defined stopping rules and ventilation procedures are implemented if concentrations exceed levels typical of household cooking. This study is designed to generate preliminary U.S.-based data on the immediate effects of cooking-related UFP exposure on respiratory function and cognitive performance. Findings will help define exposure-response patterns, support future NIH and American Lung Association proposals, and improve understanding of indoor air quality impacts in everyday environments.

Interventions

OTHERClean Indoor Air Exposure (Control)

Participants will be exposed to clean indoor air in a controlled exposure chamber with no cooking activity. This condition serves as the control session for within-subject comparisons.

OTHERExposure to Cooking-Generated Ultrafine Particles and Gases

Participants will be exposed to cooking-generated ultrafine particles and associated gases in a controlled exposure chamber during standardized cooking activities.

Sponsors

University of Illinois Chicago, Chicago, Illinois
CollaboratorUNKNOWN
University of Illinois at Chicago
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

This study uses a two-period randomized crossover design in which each participant completes both conditions: a control session with clean indoor air and an exposure session involving cooking-generated ultrafine particles. The two sessions occur on consecutive days in the same controlled exposure chamber, and participants serve as their own control to allow within-subject comparisons of respiratory and cognitive responses.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Adults 18 years of age or older Able to understand and speak English sufficiently to complete cognitive testing Able and willing to complete two consecutive study sessions lasting approximately 6 hours each Able to avoid cooking, toasting, and fume-generating household activities (e.g., strong cleaning products, ironing, hair drying) for 24 hours before each session Able to avoid tobacco, marijuana, vaping, and alcohol use as specified in the study protocol Able to provide informed consent

Exclusion criteria

Younger than 18 years old Pregnant or planning pregnancy during study participation Current smoking or use of: Cigarettes E-cigarettes or vaping devices Marijuana Shisha/hookah Binge drinking, heavy alcohol use, or inability to abstain from alcohol for 24 hours before study visits Restaurant chefs or individuals who perform frequent commercial-level cooking Individuals who cook two or more frying or grilling meals per day at home Cooking anxiety or mageirocophobia Any diagnosed neurological disease, including stroke, seizure disorder, multiple sclerosis, traumatic brain injury, dementia, or similar conditions Any significant respiratory disease, including: Chronic obstructive pulmonary disease (COPD) Untreated severe asthma Chronic bronchitis or other major lung disease Any significant psychiatric condition, including: Schizophrenia spectrum disorder Untreated substance use disorder Severe mood disorder Severe anxiety disorder Claustrophobia or anxiety in enclosed spaces (if severe enough to interfere with chamber procedures) Inability to comply with study procedures or safety requirements Any medical or psychological condition that, in the judgement of the investigators, may increase risk or interfere with study participation

Design outcomes

Primary

MeasureTime frameDescription
Change in Hopkins Verbal Learning Test-Revised (HVLT-R) Total Recall ScoreMeasured at baseline and at approximately 1, 2, 3, and 5 hours after session start on both study daysCognitive performance related to verbal memory will be assessed using the Hopkins Verbal Learning Test-Revised (HVLT-R). The primary metric will be the change in HVLT-R Total Recall Score between exposure and control conditions, calculated from repeated assessments to evaluate short-term cognitive effects of ultrafine particle exposure.
Change in Peak Expiratory Flow (PEF)Measured at baseline and at approximately 1, 2, 3, and 5 hours after session start on both study daysPeak Expiratory Flow (PEF) will be measured using a handheld peak flow meter to assess short-term changes in lung function following exposure to cooking-generated ultrafine particles compared with the clean-air control day. Changes are evaluated within subjects using repeated measurements across both conditions.
Change in WAIS Symbol Search Raw ScoreMeasured at baseline and at approximately 1, 2, 3, and 5 hours after session start on both study daysCognitive performance related to processing speed and visual attention will be assessed using the Symbol Search subtest of the Wechsler Adult Intelligence Scale (WAIS). The primary metric will be the change in WAIS Symbol Search raw score between exposure and control conditions, calculated from repeated assessments to evaluate short-term cognitive effects of ultrafine particle exposure.

Secondary

MeasureTime frameDescription
Total Volatile Organic Compound (VOC) concentration in ppmContinuously measured average concentration with one minute intervals during each study session on control and exposure days, from session start to session end (approximately 5 hours per session), across both study periodsConcentrations of over 50 volatile organic compounds (VOCs) will be monitored using FTIR spectroscopy (Gasmet DX4040) to characterize exposure to total VOC concentration during cooking. The concentration of individual gases will be add up to quantify total VOC concentration.
CO concentration in ppmContinuously measured average concentration with one minute intervals during each study session on control and exposure days, from session start to session end (approximately 5 hours per session), across both study periodsDescription: Concentrations of CO will be monitored using FTIR spectroscopy (Gasmet DX4040) to characterize exposure to CO during cooking. The
NO2 concentration in ppmContinuously measured average concentration with one minute intervals during each study session on control and exposure days, from session start to session end (approximately 5 hours per session), across both study periodsConcentrations of NO2 will be monitored using FTIR spectroscopy (Gasmet DX4040) to characterize exposure to NO2 during cooking.
CO2 concentration in ppmContinuously measured average concentration with one minute intervals during each study session on control and exposure days, from session start to session end (approximately 5 hours per session), across both study periodsDescription: Concentrations of CO2 will be monitored using Atmocube, Atmo, USA instrument. This measurement characterize exposure conditions and allow correlation with physiological responses.
Ultrafine Particle Number Size Distribution in particles/cm3Continuously measured average concentration with one minute intervals during each study session on control and exposure days, from session start to session end (approximately 5 hours per session), across both study periods.Ultrafine particle number size distributions will be measured using a Scanning Mobility Particle Sizer (SMPS) and Partector 2 Pro. These measurements characterize exposure conditions and allow correlation with physiological responses.
Fine Particle Mass Concentrations (PM2.5) in microgram/cm3Continuously measured average concentration with one minute intervals during each study session on control and exposure days, from session start to session end (approximately 5 hours per session), across both study periodsParticle mass concentrations (PM2.5) will be measured using a DustTrak DRX monitor to quantify particulate exposure profiles during cooking and control sessions. These measurements characterize exposure conditions and allow correlation with physiological responses.

Other

MeasureTime frameDescription
Temperature Condition in Exposure ChamberContinuously measured average concentration with one minute intervals during each study session on control and exposure days, from session start to session end (approximately 5 hours per session), across both study periodsAmbient temperature will be recorded to ensure environmental conditions remain consistent and to support interpretation of particle behavior.
Relative Humidity Condition in Exposure ChamberContinuously measured average concentration with one minute intervals during each study session on control and exposure days, from session start to session end (approximately 5 hours per session), across both study periodsRelative Humidity in the chamber will be recorded to ensure environmental conditions remain consistent and to support interpretation of particle behavior.
Number of Participants Reporting Acute Symptoms During Study SessionsAssessed at baseline and at approximately 1, 2, 3, and 5 hours after session start on control and exposure daysParticipant-reported symptoms related to tolerability of the study procedures and exposure will be assessed using a standardized symptom checklist administered by study staff. Symptoms assessed will include throat or eye irritation, cough, headache, dizziness, and nausea. The outcome measure will be the number of participants reporting one or more symptoms during each study session.

Countries

United States

Contacts

Primary ContactMehdi Amouei Torkmahalleh, PhD
mehdiat@uic.edu8326077765

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026